A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada, and the United States

Liver Transplantation

Volumn 10, Issue 7, 2004, Pages 898-902

  Stell, David A ^a   McAlister, Vivian C ^b   Thorburn, Douglas ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; AGE DISTRIBUTION; ALCOHOL LIVER DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; CANADA; CHOLESTASIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; DISEASE SEVERITY; FACTUAL DATABASE; FEMALE; HEALTH STATUS; HUMAN; INTENSIVE CARE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECIPIENT; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; UNITED KINGDOM; UNITED STATES;

CANADA; COHORT STUDIES; GREAT BRITAIN; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; REGISTRIES; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 3242815416     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20138     Document Type: Article

References (11)

1. Ghobrial RM, Gornbein J, Steadman R, Danino N, Markmann JF, Holt C, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002;236:315-322; discussion 322-313.
2. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:117-123.
3. Neuberger J, James O. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet 1999;354:1636-1639.
4. Edwards EB, Harper AM. Application of a continuous disease severity score to the OPTN liver waiting list. Clin Transpl 2001;19-24.
5. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
6. Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999;107:2S-9S.
7. Patrick DM, Buxton JA, Bigham M, Mathias RG. Public health and hepatitis C. Can J Public Health 2000;91(Suppl 1):S18-S21, S19-S23.
8. Balogun MA, Ramsay ME, Hesketh LM, Andrews N, Osborne KP, Gay NJ, Morgan-Capner P. The prevalence of hepatitis C in England and Wales. J Infect 2002;45:219-226.
9. Kim WR, Lindor KD, Locke GR 3rd, Therneau TM, Homburger HA, Batts KP, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000;119:1631-1636.
10. James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999;30:390-394.
11. Annual Abstract of Statistics, 2003 ed. London, United Kingdom: The Stationery Office; 2003.